Testing a non-invasive hemoglobin sensor in children having heart procedures
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is testing a new, non-invasive way to measure hemoglobin (the part of blood that carries oxygen) using a light sensor on the skin, without needing extra blood draws. The goal is to see if this sensor is accurate for children having heart procedures, which could reduce the number of needle sticks they need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 21 years old.
- You must be scheduled for a heart procedure (either heart surgery or a heart catheterization) that uses general anesthesia.
- You must have an arterial line (a small tube in an artery) placed as part of your routine care.
- You cannot have any skin, scalp, or facial conditions that would make it hard to place a small sensor on the skin.
- It must be possible to get a blood sample from the arterial line to measure hemoglobin using standard lab methods.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special sensor (near-infrared spectroscopy) that checks blood flow to the heart and other organs during heart surgery. It may help doctors monitor and improve care for children having complex heart procedures.
This trial checks how well pulse oximeters (devices that measure oxygen levels) work in children with congenital heart disease who have different skin colors. It aims to make sure these devices are accurate for all children during heart surgery.
This study is testing a new wireless device that monitors oxygen levels in the brain. It is for babies already using a similar wired monitor, to see if the wireless version works just as well.
This study measures how well blood flows to the brain in infants with serious heart defects. The results may help doctors understand and protect brain development before and after heart surgery.
This trial tests a new noninvasive method to monitor blood pressure in newborns using light sensors on the scalp. It aims to understand if this device, called FlexNIRS, can accurately track blood pressure without needing an arterial line or frequent cuff measurements.
This study tests a new oxygen sensor on children who already need a blood test from an artery. The sensor is placed on the skin and measures oxygen levels without extra needle sticks, which might make monitoring more comfortable for your child.
Hear when a new Hemoglobin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.